Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClean Power Hyd Regulatory News (CPH2)

  • This share is currently suspended. It was suspended at a price of 13.60

Share Price Information for Clean Power Hyd (CPH2)

Share Price is delayed by 15 minutes
Get Live Data
13.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £68.27m
CPH2 Live PriceLast checked at - London Stock Exchange

Intraday Clean Power Hyd Share Chart

Licenced Manufacturing Partnership with Hidrigin

23 Jun 2025 07:00

RNS Number : 8948N
Clean Power Hydrogen
23 June 2025
Β 

23 June 2025

Β 

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

Β 

CPH2 Activates First Licenced Manufacturing Partnership with Hidrigin

Β 

Β 

Highlights:

Β· First licence package submitted, enabling Hidrigin and Jones Engineering to begin manufacturing preparations for MFE220 electrolysers in Ireland

Β· Hidrigin expects construction of the units to begin in Q4 2025, with first electrolysers ready for deployment in 2026

Β· Major milestone in CPH2's commercialisation stage, advancing its capital-light licensing model

Β 

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce the submission of its first manufacturing and design licence documentation ("licence package") to Lisheen H2 Energy Park Limited, which trades under the name Hidrigin. This submission enables Hidrigin and its appointed manufacturing partner, Jones Engineering Manufacturing Limited ("Jones"), to initiate preparations for production of MFE220 electrolysers in Ireland under the existing 2GW licence agreement. The comprehensive licence package consists of: a process, mechanical, electrical and safety design package; a bill of materials with every part defined; and a 3D layout defined for the electrolyser and all sub-assemblies.

Β 

This marks a major commercial milestone for CPH2, activating its first manufacturing licensee and advancing its capital-light licensing model.

Β 

Under the 20-year licence, Hidrigin intends to deploy MFE220 electrolysers across its solar PV and wind projects in Ireland. With the submission of the licence pack, preparation activities are now underway by Hidrigin and Jones which include staff training, supplier engagement, and production facility planning. Production is scheduled to commence in Q4 2025, with the first units expected to be operational in 2026.

Β 

Β 

Jon Duffy, CEO of Clean Power Hydrogen commented:

"Activating our first licensee through the submission of this licence package to Hidrigin is a pivotal step in our commercialisation strategy. Our licensing model allows us to scale quickly and efficiently while leveraging the strengths of local partners. We are excited to support Hidrigin and Jones Engineering as they move towards production of the MFE220, and we look forward to further progress with our additional licensees during the course of 2025."

Β 

Eric Whelan, CEO of Hidrigin commented:

"Receiving the licence package from CPH2 is a major milestone in our mission to deliver green hydrogen. The technical depth and clarity of the materials give us full confidence as we begin preparations with our partners at Jones Engineering. We aim to commence production in Q4 2025 and deploy our first unit in 2026. This is the beginning of our ambition to link renewable energy with sustainable hydrogen production in Ireland and beyond."

Β 

Β 

Β 

Β 

ENDS

Β 

Β 

For more information, please contact:

Β 

Clean Power Hydrogen plc

via Camarco

Jon Duffy, Chief Executive Officer

James Hobson, Chief Financial Officer

Cavendish Capital Markets Limited - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

Camarco PR

+ 44(0) 20 3 757 4980

Owen Roberts

Kirsty Duff

Β 

To find out more, please visit: https://www.cph2.com

Β 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCPPUCCQUPAGMP
Date   Source Headline
5th Jun 20269:00 amRNSOperational Update
29th May 20267:30 amRNSSuspension - Clean Power Hydrogen PLC
29th May 20267:00 amRNS1MW MFE220 Factory Acceptance Test update
27th Apr 20267:00 amRNSMemorandum of Understanding with ABE GRUPPE GmbH
7th Apr 20267:00 amRNSMemorandum of Understanding with Koch Modular
30th Mar 20267:00 amRNSOperations & Trading Update
24th Mar 20267:00 amRNSMemorandum of Understanding with Siemens
19th Feb 20267:00 amRNS-RInvestor Webinar
29th Jan 20267:00 amRNSAppointment of Joint Broker
18th Dec 20257:00 amRNSSignificant Milestones Delivered
5th Nov 20257:00 amRNS-RMello2025 Investor Event
24th Oct 20257:00 amRNSAward under Salary Sacrifice Scheme
3rd Oct 20257:00 amRNSAward under the Company’s Long-Term Incentive Plan
30th Sep 20257:00 amRNSInterim Results
26th Sep 20257:00 amRNSAppointment of Chief Operations Director
26th Sep 20257:00 amRNSTR-1: Notification of major holdings
24th Sep 20253:58 pmRNSTR-1: Notification of major holdings
24th Sep 20253:48 pmRNSTR-1: Notification of major holdings
24th Sep 20253:48 pmRNSTR-1: Notification of major holdings
24th Sep 20253:44 pmRNSTR-1: Notification of major holdings
24th Sep 20253:41 pmRNSTR-1: Notification of major holdings
18th Sep 202512:26 pmRNSResult of General Meeting and Total Voting Rights
4th Sep 20257:00 amRNSResults of Oversubscribed Retail Offer
28th Aug 20254:35 pmRNSRetail Offer to Raise up to £300,000
28th Aug 20254:13 pmRNSResult of Placing and Subscription
28th Aug 20257:00 amRNSProposed Placing, Subscription, and Retail Offer
31st Jul 20257:00 amRNSCorporate Update and Proposed Fundraising
1st Jul 20257:00 amRNSWastewater Treatment Efficiency Gains
27th Jun 20257:00 amRNSManufacturing Partnership with Kenera
23rd Jun 20257:00 amRNSLicenced Manufacturing Partnership with Hidrigin
19th Jun 20251:08 pmRNSResult of AGM
16th Jun 20257:00 amRNSMemorandum of Understanding with Constant Energy
5th Jun 20257:00 amRNS2025 Save as You Earn Scheme
30th May 20257:00 amRNSAwards under the Long-Term Incentive Plan
21st May 20257:00 amRNSPosting of Annual Report and Notice of AGM
20th May 20257:00 amRNS-RLongspur Research initiates coverage on CPH2
7th May 202511:23 amRNSSite Acceptance Test for MFE110 electrolyser
1st May 20257:00 amRNSFinal Results
22nd Apr 20257:00 amRNSNotice of Results
22nd Apr 20257:00 amRNSAppointment of Chief Commercial Officer
12th Mar 20257:00 amRNSLevel 2 of Site Acceptance Test Completed
24th Feb 20257:00 amRNSLevel 1 of Site Acceptance Test Completed
16th Jan 20259:21 amRNSIssue of Ordinary Shares
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.